Inspire Medical Systems shareholders approve board declassification and equity plan
At its April 30, 2026 annual meeting, Inspire Medical Systems stockholders approved phasing out the classified board, with all directors elected annually starting in 2029, and approved an amended 2018 Incentive Award Plan that adds 2,600,000 shares and removes the evergreen share increase. The equity plan passed with 14,330,536 votes for and 8,796,686 against, so shareholders should note the sizable opposition alongside the approval.
Key points
- Declassification amendment approved: 23,121,710 votes for and 11,103 against, with all directors elected annually beginning with the 2029 annual meeting
- Amended 2018 Incentive Award Plan authorizes 9,903,857 shares, including an increase of 2,600,000 shares, and runs through March 6, 2036
- Plan approval: 14,330,536 votes for and 8,796,686 against; about 88% of common stock outstanding as of the March 2, 2026 record date was represented
- Gary L. Ellis received 5,883,344 votes withheld, the largest withhold count among the three director nominees, all of whom were elected
The filing
Written by AI on Nov 8, 2026, 1:55 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on May 05, 2026.
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.